Eriacta is a prescription medication containing sildenafil citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor clinically proven to address erectile dysfunction. It works by enhancing blood flow to the penile tissues, facilitating a firm and sustained erection when sexually stimulated. This medication is intended for adult males and requires appropriate medical evaluation prior to use to ensure safety and efficacy. Proper administration is crucial for achieving optimal therapeutic outcomes while minimizing potential risks.

Features

• Active ingredient: Sildenafil Citrate 100mg
• Pharmaceutical form: Film-coated tablets
• Mechanism: Selective inhibition of phosphodiesterase type 5 (PDE5)
• Onset of action: Typically within 30–60 minutes
• Duration of effect: Up to 4–6 hours
• Manufactured under strict GMP standards

Benefits

• Restores the natural physiological process for achieving and maintaining erections
• Provides a reliable therapeutic window for spontaneous sexual activity
• Improves confidence and reduces anxiety related to sexual performance
• Enhances overall sexual satisfaction for both partners
• Supported by extensive clinical research and real-world evidence
• Offers a cost-effective alternative within its therapeutic class

Common use

Eriacta is primarily indicated for the treatment of erectile dysfunction (ED) in adult males. It is used to improve erectile function by increasing blood flow to the penis, which is necessary to achieve and maintain an erection sufficient for sexual intercourse. It is not indicated for use by women, children, or adolescents. The medication requires sexual stimulation to be effective and does not increase libido.

Dosage and direction

The recommended starting dose for most patients is 50mg taken approximately one hour before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 100mg or decreased to 25mg. The maximum recommended dosing frequency is once per day. Tablets should be swallowed whole with a glass of water and may be taken with or without food, though high-fat meals may delay onset of action.

Precautions

Patients with cardiovascular disease should undergo thorough evaluation before initiating treatment. Sexual activity poses potential cardiac risk, particularly in those with pre-existing heart conditions. Use with caution in patients with anatomical penile deformation, bleeding disorders, or active peptic ulceration. Priapism (prolonged erection lasting more than 4 hours) requires immediate medical attention to prevent permanent tissue damage.

Contraindications

Concomitant use with organic nitrates or nitric oxide donors in any form. Hypersensitivity to sildenafil or any component of the formulation. Patients with severe hepatic impairment, severe hypotension, recent stroke or myocardial infarction, or unstable angina. Hereditary degenerative retinal disorders, including retinitis pigmentosa.

Possible side effects

• Headache (15%)
• Flushing (10%)
• Dyspepsia (7%)
• Nasal congestion (4%)
• Visual disturbances (3%)
• Dizziness (2%)
• Back pain/myalgia (2%)
• Less common: palpitations, hypotension, priapism, sudden hearing loss

Drug interaction

Concomitant use with nitrates is absolutely contraindicated. Potent CYP3A4 inhibitors (ketoconazole, ritonavir) may increase sildenafil concentrations—dose adjustment required. Alpha-blockers may potentiate hypotensive effects. Grapefruit juice may increase bioavailability. Interactions with other antihypertensives may produce additive blood pressure lowering effects.

Missed dose

Eriacta is taken on an as-needed basis rather than a scheduled regimen. No specific instructions apply for missed doses. Do not take a double dose to make up for a missed tablet.

Overdose

Symptoms may include severe headache, visual disturbances, dizziness, syncope, and prolonged erection. Standard supportive measures should be implemented as appropriate. Hemodialysis is not expected to enhance clearance due to high protein binding and extensive tissue distribution.

Storage

Store at room temperature (15–30°C) in original packaging. Protect from light and moisture. Keep out of reach of children. Do not use after expiration date printed on packaging.

Disclaimer

This information is for educational purposes only and does not replace professional medical advice. Always consult a healthcare provider for proper diagnosis and treatment recommendations. Do not initiate or discontinue medication without medical supervision.

Reviews

Clinical studies demonstrate 82% improvement in erectile function compared to 24% with placebo. Patient satisfaction surveys indicate 76% reported improved ability to achieve erection and 68% reported maintained improvement in sexual function. Real-world evidence supports sustained efficacy with proper use and appropriate patient selection.